MyFinsight
Home
Blog
About
Contact
Cash and cash
equivalents
$274,161K
Short-term investments
$196,277K
Prepaid expenses and
other current assets
$44,761K
Equity investments
$5,861K
Restricted cash and cash
equivalents, current
$1,925K
Total current assets
$522,985K
Long-term investments
$332,970K
Operating right-of-use
assets
$60,760K
Property and equipment,
net
$53,158K
Other assets
$24,042K
Goodwill
$16,937K
Intangible assets, net
$7,777K
Restricted cash and cash
equivalents, noncurrent
$6,956K
Total assets
$1,025,585K
Total liabilities and
stockholders equity
$1,025,585K
Total stockholders
equity
$812,765K
Total liabilities
$212,820K
Accumulated deficit
-$1,323,466K
Accumulated other
comprehensive loss
-$3,483K
Additional paid-in capital
$2,139,698K
Operating lease
liabilities, noncurrent
$86,635K
Total current
liabilities
$73,558K
Contingent consideration
obligation, noncurrent
$33,210K
Other long-term
liabilities
$19,417K
Common stock, 0.0001
par value...
$16K
Accrued and other
liabilities
$68,113K
Accounts payable
$5,445K
Back
Back
Balance Sheet
Vir Biotechnology, Inc. (VIR)
Vir Biotechnology, Inc. (VIR)
source: myfinsight.com